Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07822061) titled 'AMAZE 10: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People in Japan With Excess Body Weight Lose Weight' on Sept. 10.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Novo Nordisk A/S
Condition:
Overweight
Obesity
Intervention:
Drug: NNC0487-0111
Recruitment Status: Recruiting
Phase: Phase 3
Date of First Enrollment: September 7, 2026
Target Sample Size: 400
Countries of Recruitment:
Japan
...